EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSPKIG00000002343
Gene Symbol: MAP3K9
3 Cross references
195 Possible Orthologues:

Monoamine Oxidase A

Ensembl ID : ENSPKIG00000017194
Gene Symbol: MAOA
3 Cross references
148 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSPKIG00000024168
Gene Symbol: MGLL
1 Cross references
206 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSPKIG00000014070
Gene Symbol: MGLL
3 Cross references
206 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSPKIG00000021830
Gene Symbol: MLNR
3 Cross references
165 Possible Orthologues:

Mu-Type Opioid Receptor-Like

Ensembl ID : ENSPKIG00000006065
Gene Symbol: LOC111855090
3 Cross references
214 Possible Orthologues:

Muscarinic Acetylcholine Receptor M2-Like

Ensembl ID : ENSPKIG00000003467
Gene Symbol: LOC111843396
3 Cross references
195 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSPKIG00000014393
Gene Symbol: NPR1
3 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSPKIG00000025584
Gene Symbol: NPR2
2 Cross references
184 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2-Like

Ensembl ID : ENSPKIG00000015156
Gene Symbol: LOC111849200
3 Cross references
199 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7-Like

Ensembl ID : ENSPKIG00000017165
Gene Symbol: LOC111845602
3 Cross references
248 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7-Like

Ensembl ID : ENSPKIG00000009303
Gene Symbol: LOC111836040
2 Cross references
140 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).